Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on March 12, 2024, reporting an event that occurred on March 7, 2024. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing discloses a specific financing transaction but does not provide comprehensive financial statements for the period.
- Debt Issuance: The company issued a Promissory Note for $500,000.
- Interest Rate: 12% per annum.
- Maturity Date: March 7, 2026.
- Revenue, Profit, Cash Flow, Margins: The filing text does not provide a clear value for these metrics.
- Liquidity: No specific liquidity ratios or cash balance figures are provided in this report.
Material Changes
The primary material change is the entry into a Material Definitive Agreement (Item 1.01). The company increased its debt obligations by $500,000 through the issuance of the 12% Note due 2026. This transaction was executed pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of general business risks. The Note includes customary events of default. The company retains the right to prepay all or any portion of the principal without penalty.
Investor Verification Checklist
- Verify the total outstanding debt load of BioSig Technologies, Inc. following this $500,000 issuance.
- Confirm the identity of the investor receiving the Promissory Note.
- Review the company's most recent 10-Q or 10-K to assess current cash flow sufficiency to service the 12% interest payments.
- Check for any subsequent filings regarding the use of proceeds from this note.